Hudson Bay Capital Management LP Biotechnology

Hudson Bay Capital Management LP

Stock	Option Type	Value	Options Held	Last Trade
VRTX Vertex Pharmaceuticals Inc	PUT	$24.1 Million	49.8K	Q1 2025 Added 397.66%
NVO Novo Nordisk A S	PUT	$17.4 Million	250K	Q4 2024 Added 438.47%
ALNY Alnylam Pharmaceuticals, Inc.	PUT	$10.8 Million	40K	Q4 2024 Reduced 58.93%
REGN Regeneron Pharmaceuticals, Inc.	PUT	$9.89 Million	15.6K	Q1 2025 Added 37.19%
INSM Insmed Inc	CALL	$7.63 Million	100K	Q1 2025 Reduced 80.87%
VRTX Vertex Pharmaceuticals Inc	CALL	$5.53 Million	11.4K	Q1 2025 Added 397.66%
BBIO Bridge Bio Pharma, Inc.	CALL	$3.46 Million	100K	Q1 2025 Added 33.29%
REGN Regeneron Pharmaceuticals, Inc.	CALL	$1.97 Million	3.1K	Q1 2025 Added 37.19%
EWTX Edgewise Therapeutics, Inc.	PUT	$1.1 Million	50K	Q3 2024 New holding
EWTX Edgewise Therapeutics, Inc.	CALL	$1.1 Million	50K	Q3 2024 New holding
KALV Kal Vista Pharmaceuticals, Inc.	CALL	$461,000	40K	N/A
MNKD Mannkind Corp	CALL	$377,000	75K	Q1 2025 New holding
CMPX Compass Therapeutics, Inc.	CALL	$254,000	134K	Q4 2022 New holding
CNTA Centessa Pharmaceuticals PLC	PUT	$251,000	17.5K	N/A
CNTA Centessa Pharmaceuticals PLC	CALL	$251,000	17.5K	N/A

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.